gsk glp-1 GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice GLP-1 Receptor Agonist Services for

10.1016/j.bbrc.2004.09.021 77 LenzenS.LortzS.TiedgeM

Mounjaro (tirzepatide) uniquely targets both GLP-1 and GIP receptors, potentially offering more substantial weight reduction and improved glycemic control compared to other GLP-1RAs that only target the GLP-1 receptor, such as Ozempic (semaglutide)

In a small exploratory trial published last year, liraglutide reduced monthly migraine episodes by half in migraine patients with obesity

GLP-1 medications include commonly used names like Ozempic, Wegovy and Mounjaro, which were although originally designed for diabetes treatment, are now used majorly as weight loss drugs